GlassScriptPhysician profile
Ilya Perepelitsyn
NPI 1992795058
$4,051.50
in general payments reported to CMS, 2019-2025
17 companies · $426 in 2025
The $426 reported for 2025 was more than what a typical Otolaryngology/Facial Plastic Surgery provider received nationally (typical 2025 total: $305).
See the full distribution for Otolaryngology/Facial Plastic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,291 · 2020: $1,238 · 2021: $217 · 2022: $89.52 · 2023: $478 · 2024: $312 · 2025: $426.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,216.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,215.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Inspire Medical Systems, INC. | $1,898.52 | 2020-2025 | Inspire |
| Medical Device Business Services, INC. | $873.46 | 2019 | |
| Stryker Corporation | $199.71 | 2019-2025 | Scopis Ent |
| Aerin Medical INC. | $199.19 | 2020-2025 | |
| Acclarent, INC | $195.75 | 2019 | |
| Medtronic USA, INC. | $149.53 | 2019 | |
| Glaxosmithkline, LLC. | $113.82 | 2021-2025 | Nucala |
| Genzyme Corporation | $79.19 | 2019-2025 | |
| Optinose US, INC. | $67.37 | 2020-2024 | |
| Intersect Ent, INC. | $67.26 | 2020 | |
| Microtransponder, INC. | $55.14 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $46.06 | 2021-2025 | Dupixent |
| Itamar Medical INC | $45.85 | 2022-2023 | Watchpatone |
| Med-El Corporation | $16.83 | 2022 | |
| Oyster Point Pharma, INC. | $15.60 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phadia US INC. | $15.19 | 2024 | Immunocap |
| Smith+Nephew, INC. | $13.03 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ilya Perepelitsyn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.